Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China · Delayed Price · Currency is CNY 11.52
-0.54 (-4.48%)
Oct 23, 2026, 3:04 PM CST
SHE:300452 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 202.64 | 299.42 | 192.69 | 173.96 | 150.12 | 141.26 |
Trading Asset Securities | 673.72 | 521.55 | 515.63 | 511.77 | 214.56 | 187.88 |
Cash & Short-Term Investments | 876.35 | 820.97 | 708.32 | 685.73 | 364.68 | 329.14 |
Cash Growth | 20.32% | 15.90% | 3.29% | 88.03% | 10.80% | 9.55% |
Accounts Receivable | 234.99 | 221.92 | 204.73 | 145.57 | 123.39 | 129.53 |
Other Receivables | 0.7 | 0.64 | 1.05 | 0.59 | 0.59 | 0.26 |
Receivables | 235.69 | 222.56 | 205.78 | 146.16 | 123.98 | 129.79 |
Inventory | 101.81 | 92.26 | 88.76 | 94.1 | 91.2 | 77.77 |
Other Current Assets | 17.76 | 15.99 | 18.67 | 13.37 | 51.46 | 16.12 |
Total Current Assets | 1,232 | 1,152 | 1,022 | 939.37 | 631.32 | 552.82 |
Property, Plant & Equipment | 486.22 | 496.19 | 476.45 | 503.57 | 439.83 | 305.04 |
Goodwill | - | - | - | 39.13 | 39.13 | 39.13 |
Other Intangible Assets | 79.03 | 54.99 | 51.22 | 52.37 | 53.66 | 54.48 |
Long-Term Deferred Tax Assets | 4.68 | 4.66 | 5.96 | 5.97 | 12.66 | 8.13 |
Long-Term Deferred Charges | 4.09 | 3.51 | 2.19 | 1.6 | 0.98 | 0.46 |
Other Long-Term Assets | 4.98 | 1.77 | 2.37 | 0.71 | 2.97 | 2.52 |
Total Assets | 1,811 | 1,713 | 1,560 | 1,543 | 1,181 | 962.58 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 231.94 | 219.26 | 186.09 | 219.23 | 225.95 | 132.26 |
Accrued Expenses | 9.11 | 21.42 | 17.74 | 17.74 | 14.74 | 12.48 |
Short-Term Debt | 31.02 | 5.52 | 6.46 | 10.01 | 39.84 | 31.04 |
Current Income Taxes Payable | 11.8 | 11.27 | 0.02 | 4.07 | 0.04 | 3.12 |
Current Unearned Revenue | 13.74 | 8.02 | 7.09 | 6.82 | 22.58 | 11.45 |
Other Current Liabilities | 17.5 | 12.76 | 16.07 | 15.49 | 42.1 | 32.92 |
Total Current Liabilities | 315.1 | 278.26 | 233.47 | 273.36 | 345.25 | 223.26 |
Long-Term Debt | 316.45 | 309.19 | 298.51 | 287.59 | - | - |
Long-Term Unearned Revenue | 33.81 | 34.97 | 33.49 | 35 | 31.13 | 27.76 |
Long-Term Deferred Tax Liabilities | 13.59 | 16.78 | 18.95 | 11.51 | 15.56 | 5.64 |
Total Liabilities | 678.95 | 639.2 | 584.43 | 607.46 | 391.93 | 256.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 234.46 | 234.45 | 234.45 | 234.46 | 234.52 | 180.47 |
Additional Paid-In Capital | 65.61 | 65.54 | 65.51 | 65.58 | 65.81 | 65.64 |
Retained Earnings | 754.51 | 698.92 | 592.15 | 530.88 | 427.94 | 405.45 |
Treasury Stock | -22.51 | -22.51 | -22.51 | -0.21 | -5.83 | -12.13 |
Comprehensive Income & Other | 31.94 | 30.25 | 35.41 | 35.39 | 0.07 | 0.57 |
Total Common Equity | 1,064 | 1,007 | 905.01 | 866.09 | 722.52 | 640 |
Minority Interest | 67.65 | 67.04 | 70.29 | 69.15 | 66.1 | 65.92 |
Shareholders' Equity | 1,132 | 1,074 | 975.3 | 935.25 | 788.62 | 705.92 |
Total Liabilities & Equity | 1,811 | 1,713 | 1,560 | 1,543 | 1,181 | 962.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 347.47 | 314.71 | 304.98 | 297.6 | 39.84 | 31.04 |
Net Cash (Debt) | 528.89 | 506.26 | 403.35 | 388.13 | 324.84 | 298.11 |
Net Cash Growth | 26.88% | 25.51% | 3.92% | 19.48% | 8.97% | 14.45% |
Net Cash Per Share | 2.19 | 2.09 | 1.72 | 1.61 | 1.39 | 1.27 |
Filing Date Shares Outstanding | 240.49 | 232.63 | 232.62 | 237.2 | 223.93 | 237.49 |
Total Common Shares Outstanding | 240.49 | 232.63 | 232.62 | 237.2 | 223.93 | 237.49 |
Working Capital | 916.51 | 873.51 | 788.06 | 666.01 | 286.07 | 329.56 |
Book Value Per Share | 4.42 | 4.33 | 3.89 | 3.65 | 3.23 | 2.69 |
Tangible Book Value | 984.98 | 951.67 | 853.79 | 774.6 | 629.73 | 546.39 |
Tangible Book Value Per Share | 4.10 | 4.09 | 3.67 | 3.27 | 2.81 | 2.30 |
Buildings | - | 237.56 | 237.1 | 236.38 | 180.15 | 176.81 |
Machinery | - | 380.92 | 359.04 | 291.82 | 214.45 | 204.84 |
Construction In Progress | - | 57.06 | 11.54 | 86.49 | 154.59 | 6.49 |